Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro.

Chakravarthy M, AlShamaileh H, Huang H, Tannenberg RK, Chen S, Worrall S, Dodd PR, Veedu RN.

Chem Commun (Camb). 2018 May 1;54(36):4593-4596. doi: 10.1039/c8cc02256a.

PMID:
29670956
2.

Metabolic strategies for the degradation of the neuromodulator agmatine in mammals.

Benítez J, García D, Romero N, González A, Martínez-Oyanedel J, Figueroa M, Salas M, López V, García-Robles M, Dodd PR, Schenk G, Carvajal N, Uribe E.

Metabolism. 2018 Apr;81:35-44. doi: 10.1016/j.metabol.2017.11.005. Epub 2017 Nov 21. Review.

PMID:
29162499
3.

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

Chakravarthy M, Chen S, Dodd PR, Veedu RN.

Theranostics. 2017 Sep 5;7(16):3933-3947. doi: 10.7150/thno.21529. eCollection 2017. Review.

4.

Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs.

Toselli F, Dodd PR, Gillam EM.

Drug Metab Rev. 2016 Aug;48(3):379-404. doi: 10.1080/03602532.2016.1221960. Review.

PMID:
27498925
5.

Differential expression of α-synuclein splice variants in the brain of alcohol misusers: Influence of genotype.

Janeczek P, Brooker C, Dodd PR, Lewohl JM.

Drug Alcohol Depend. 2015 Oct 1;155:284-92. doi: 10.1016/j.drugalcdep.2015.05.045. Epub 2015 Aug 7.

PMID:
26297298
6.

Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR.

Toselli F, de Waziers I, Dutheil M, Vincent M, Wilce PA, Dodd PR, Beaune P, Loriot MA, Gillam EM.

Xenobiotica. 2015;45(12):1129-37. doi: 10.3109/00498254.2015.1040102. Epub 2015 Jun 22.

PMID:
26095139
7.

SWATH analysis of the synaptic proteome in Alzheimer's disease.

Chang RY, Etheridge N, Nouwens AS, Dodd PR.

Neurochem Int. 2015 Aug;87:1-12. doi: 10.1016/j.neuint.2015.04.004. Epub 2015 May 6.

PMID:
25958317
8.

New insights into Alzheimer's disease pathogenesis: the involvement of neuroligins in synaptic malfunction.

Sindi IA, Dodd PR.

Neurodegener Dis Manag. 2015;5(2):137-45. doi: 10.2217/nmt.14.54. Review.

PMID:
25894877
9.

Expression of CYP2E1 and CYP2U1 proteins in amygdala and prefrontal cortex: influence of alcoholism and smoking.

Toselli F, Booth Depaz IM, Worrall S, Etheridge N, Dodd PR, Wilce PA, Gillam EM.

Alcohol Clin Exp Res. 2015 May;39(5):790-7. doi: 10.1111/acer.12697.

PMID:
25872594
10.

Multiple reaction monitoring for the detection of disease-related synaptic proteins.

Chang RY, Dodd PR.

Neural Regen Res. 2014 Dec 1;9(23):2042-3. doi: 10.4103/1673-5374.147926. No abstract available.

11.

Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.

Rahman T, Davies DS, Tannenberg RK, Fok S, Shepherd C, Dodd PR, Cullen KM, Goldsbury C.

J Alzheimers Dis. 2014;42(4):1443-60. doi: 10.3233/JAD-140393.

PMID:
25024349
12.

Targeted quantitative analysis of synaptic proteins in Alzheimer's disease brain.

Chang RY, Etheridge N, Dodd PR, Nouwens AS.

Neurochem Int. 2014 Sep;75:66-75. doi: 10.1016/j.neuint.2014.05.011. Epub 2014 Jun 2.

PMID:
24893329
13.

Role for the neurexin-neuroligin complex in Alzheimer's disease.

Sindi IA, Tannenberg RK, Dodd PR.

Neurobiol Aging. 2014 Apr;35(4):746-56. doi: 10.1016/j.neurobiolaging.2013.09.032. Epub 2013 Nov 6. Review.

PMID:
24211009
14.

Dependent heroin use and associated risky behaviour: the role of rash impulsiveness and reward sensitivity.

Dissabandara LO, Loxton NJ, Dias SR, Dodd PR, Daglish M, Stadlin A.

Addict Behav. 2014 Jan;39(1):71-6. doi: 10.1016/j.addbeh.2013.06.009. Epub 2013 Jun 14.

PMID:
24112954
15.

Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology.

Tannenberg RK, Shamaileh HA, Lauridsen LH, Kanwar JR, Dodd PR, Veedu RN.

Curr Alzheimer Res. 2013 May 1;10(4):442-8. Review.

PMID:
23270374
16.

The synaptic proteome in Alzheimer's disease.

Chang RY, Nouwens AS, Dodd PR, Etheridge N.

Alzheimers Dement. 2013 Sep;9(5):499-511. doi: 10.1016/j.jalz.2012.04.009. Epub 2012 Nov 13.

PMID:
23154051
17.

Reduced expression of α-synuclein in alcoholic brain: influence of SNCA-Rep1 genotype.

Janeczek P, MacKay RK, Lea RA, Dodd PR, Lewohl JM.

Addict Biol. 2014 May;19(3):509-15. doi: 10.1111/j.1369-1600.2012.00495.x. Epub 2012 Sep 13.

18.

mGlu5 Receptor Functional Interactions and Addiction.

Brown RM, Mustafa S, Ayoub MA, Dodd PR, Pfleger KD, Lawrence AJ.

Front Pharmacol. 2012 May 7;3:84. doi: 10.3389/fphar.2012.00084. eCollection 2012.

19.

Identifying changes in the synaptic proteome of cirrhotic alcoholic superior frontal gyrus.

Etheridge N, Mayfield RD, Harris RA, Dodd PR.

Curr Neuropharmacol. 2011 Mar;9(1):122-8. doi: 10.2174/157015911795017164.

20.

Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists.

Ali SF, Onaivi ES, Dodd PR, Cadet JL, Schenk S, Kuhar MJ, Koob GF.

Curr Neuropharmacol. 2011 Mar;9(1):2-7. doi: 10.2174/157015911795017245.

21.

Electrically evoked synaptosomal amino acid transmitter release in human brain in alcohol misuse.

Kuo SW, Dodd PR.

Neurosignals. 2011;19(3):117-27. doi: 10.1159/000326842. Epub 2011 Aug 11.

22.

Up-regulation of microRNAs in brain of human alcoholics.

Lewohl JM, Nunez YO, Dodd PR, Tiwari GR, Harris RA, Mayfield RD.

Alcohol Clin Exp Res. 2011 Nov;35(11):1928-37. doi: 10.1111/j.1530-0277.2011.01544.x. Epub 2011 Jun 8.

23.

Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.

Proctor DT, Coulson EJ, Dodd PR.

Prog Neurobiol. 2011 Apr;93(4):509-21. doi: 10.1016/j.pneurobio.2011.02.002. Epub 2011 Mar 4. Review.

PMID:
21382433
24.

Differential expression of 14-3-3 isoforms in human alcoholic brain.

MacKay RK, Colson NJ, Dodd PR, Lewohl JM.

Alcohol Clin Exp Res. 2011 Jun;35(6):1041-9. doi: 10.1111/j.1530-0277.2011.01436.x. Epub 2011 Feb 17.

25.

Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue.

Gebhardt FM, Scott HA, Dodd PR.

Alzheimers Dement. 2010 Nov;6(6):465-74. doi: 10.1016/j.jalz.2009.11.002.

PMID:
21044776
26.

Exon-skipping splice variants of excitatory amino acid transporter-2 (EAAT2) form heteromeric complexes with full-length EAAT2.

Gebhardt FM, Mitrovic AD, Gilbert DF, Vandenberg RJ, Lynch JW, Dodd PR.

J Biol Chem. 2010 Oct 8;285(41):31313-24. doi: 10.1074/jbc.M110.153494. Epub 2010 Aug 5.

27.

Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.

Proctor DT, Coulson EJ, Dodd PR.

J Alzheimers Dis. 2010;21(3):795-811. doi: 10.3233/JAD-2010-100090.

PMID:
20634587
28.

Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics.

Ho AM, MacKay RK, Dodd PR, Lewohl JM.

Brain Res. 2010 Jun 22;1340:1-9. doi: 10.1016/j.brainres.2010.04.049. Epub 2010 Apr 27.

29.

Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.

Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR.

Neurobiol Aging. 2011 Mar;32(3):553.e1-11. doi: 10.1016/j.neurobiolaging.2010.03.008. Epub 2010 Apr 22.

PMID:
20416976
30.

Patterns of substance use in male incarcerated drug users in Sri Lanka.

Dissabandara LO, Dias SR, Dodd PR, Stadlin A.

Drug Alcohol Rev. 2009 Nov;28(6):600-7. doi: 10.1111/j.1465-3362.2009.00062.x.

PMID:
19930012
31.

Synaptic proteome changes in the superior frontal gyrus and occipital cortex of the alcoholic brain.

Etheridge N, Lewohl JM, Mayfield RD, Harris RA, Dodd PR.

Proteomics Clin Appl. 2009 Jun 24;3(6):730-742.

32.

Ecophysiology of neuronal metabolism in transiently oxygen-depleted environments: evidence that GABA is accumulated pre-synaptically in the cerebellum.

Renshaw GM, Wise G, Dodd PR.

Comp Biochem Physiol A Mol Integr Physiol. 2010 Apr;155(4):486-92. doi: 10.1016/j.cbpa.2009.10.039. Epub 2009 Nov 3.

PMID:
19892031
33.

Sex differences in NMDA receptor expression in human alcoholics.

Ridge JP, Ho AM, Dodd PR.

Alcohol Alcohol. 2009 Nov-Dec;44(6):594-601. doi: 10.1093/alcalc/agp052. Epub 2009 Sep 7.

34.

Cortical NMDA receptor expression in human chronic alcoholism: influence of the TaqIA allele of ANKK1.

Ridge JP, Dodd PR.

Neurochem Res. 2009 Oct;34(10):1775-82. doi: 10.1007/s11064-009-9941-8. Epub 2009 Mar 13.

PMID:
19283474
35.

A brain bank for Sri Lanka.

De Silva KR, Shankar SK, Mahadevan A, Dodd PR.

Ceylon Med J. 2008 Dec;53(4):139-40. No abstract available.

PMID:
19189795
36.

Regional expression of dopamine D1 and D2 receptor proteins in the cerebral cortex of asphyxic newborn infants.

Kaewsuk S, Tannenberg RK, Kuo SW, Björkman ST, Govitrapong P, Stadlin A, Dodd PR.

J Child Neurol. 2009 Feb;24(2):183-93. doi: 10.1177/0883073808322669.

PMID:
19182156
37.

The expression of NMDA receptor subunit mRNA in human chronic alcoholics.

Ridge JP, Ho AM, Innes DJ, Dodd PR.

Ann N Y Acad Sci. 2008 Oct;1139:10-9. doi: 10.1196/annals.1432.053.

38.

Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer's disease.

Agarwal S, Tannenberg RK, Dodd PR.

J Alzheimers Dis. 2008 Jul;14(3):313-21.

PMID:
18599957
39.

Upregulation of beta-catenin levels in superior frontal cortex of chronic alcoholics.

Al-Housseini AM, Sivanandam TM, Bradbury EL, Tannenberg RK, Dodd PR, Gu Q.

Alcohol Clin Exp Res. 2008 Jun;32(6):1080-90. doi: 10.1111/j.1530-0277.2008.00670.x. Epub 2008 Apr 26.

PMID:
18445113
40.

Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics.

Liu J, Lewohl JM, Harris RA, Dodd PR, Mayfield RD.

Alcohol Clin Exp Res. 2007 Sep;31(9):1460-6. Epub 2007 Jul 11.

PMID:
17625000
41.

Glutamate-glutamine cycling in Alzheimer's disease.

Walton HS, Dodd PR.

Neurochem Int. 2007 Jun;50(7-8):1052-66. Epub 2006 Dec 1. Review.

PMID:
17141374
42.

Genes and gene expression in the brains of human alcoholics.

Dodd PR, Buckley ST, Eckert AL, Foley PF, Innes DJ.

Ann N Y Acad Sci. 2006 Aug;1074:104-15.

PMID:
17105908
43.

Analysis of multiple exon-skipping mRNA splice variants using SYBR Green real-time RT-PCR.

Walton HS, Gebhardt FM, Innes DJ, Dodd PR.

J Neurosci Methods. 2007 Mar 15;160(2):294-301. Epub 2006 Nov 13.

PMID:
17097739
44.

Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.

Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR.

Neurochem Int. 2006 Dec;49(7):631-9. Epub 2006 Jun 30.

PMID:
16814428
45.

GABA(A) receptor beta isoform protein expression in human alcoholic brain: interaction with genotype.

Buckley ST, Foley PF, Innes DJ, Loh el-W, Shen Y, Williams SM, Harper CG, Tannenberg AE, Dodd PR.

Neurochem Int. 2006 Nov;49(6):557-67.

PMID:
16766085
46.

NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.

Ragnarsson L, Yasuda T, Lewis RJ, Dodd PR, Adams DJ.

J Neurochem. 2006 Jan;96(1):283-91. Epub 2005 Nov 29.

47.

Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals.

Liu J, Lewohl JM, Harris RA, Iyer VR, Dodd PR, Randall PK, Mayfield RD.

Neuropsychopharmacology. 2006 Jul;31(7):1574-82. Epub 2005 Nov 2.

48.

Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain.

Lewohl JM, Wixey J, Harper CG, Dodd PR.

Alcohol Clin Exp Res. 2005 Sep;29(9):1698-705.

PMID:
16205370
49.

Alcoholic neurobiology: changes in dependence and recovery.

Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh el-W, Pfefferbaum A, Zou J, Sullivan EV.

Alcohol Clin Exp Res. 2005 Aug;29(8):1504-13.

PMID:
16156047
50.

The identification and characterization of excitotoxic nerve-endings in Alzheimer disease.

Tannenberg RK, Scott HL, Westphalen RI, Dodd PR.

Curr Alzheimer Res. 2004 Feb;1(1):11-25. Review.

PMID:
15975081

Supplemental Content

Support Center